Johnson & Johnson Wound Management, division of ETHICON, INC, a Johnson & Johnson company, today announced PROMOGRAN
PRISMA� Matrix as the latest addition to their family of chronic wound dressings. Developed to provide protection and growth
in a changing wound environment, PRIMSA� Matrix absorbs destructive components of wound exudate while promoting healthy
tissue healing.
The unique combination of collagen, oxidized regenerated cellulose (ORC) and silver-ORC� delivers a balanced combination of protection and growth for a variety of wound types and conditions at any exudate level. PRISMA� Matrix removes destructive elements and components in wound fluid, kills clinically relevant bacteria in the dressing to help maintain bacterial balance and reduces bacterial growth, which may reduce the risk of infection. The dressing also promotes healthy tissue growth while delivering silver to the wound. The collagen provides a biodegradable matrix for cellular invasion and capillary growth while creating an environment that promotes the formation of granulation tissue, epithelialization and optimal wound healing.
"With PRISMA� Matrix, Johnson & Johnson Wound Management continues its pioneering role as a wound care industry leader," stated William Li, M.D., president of the Angiogenesis Foundation in Cambridge, MA. "This single product is an integrated technology that addresses multiple factors causing impaired healing. PRISMA� Matrix can be used as part of the standard approach to restoring proper balance in the wound bed to promote successful healing."
PRISMA� Matrix is intended for the management of exuding wounds. Under the supervision of a health care professional, PRISMA� Matrix may be used for the management of diabetic, venous and pressure ulcers, ulcers caused by mixed vascular etiologies, full- and partial-thickness wounds, donor sites and other bleeding surface wounds, abrasions, traumatic wounds healing by secondary intention and dehisced surgical wounds. PRISMA� Matrix may be used under compression therapy with health care professional supervision.
PRISMA� Matrix is not indicated for third-degree burns or patients with known sensitivity to silver, ORC or collagen. PRISMA� Matrix may be used when visible signs of infection are present in the wound area only when proper medical treatment addresses the underlying cause. PRISMA� Matrix is not intended to be a substitute for appropriate treatment of infection.
Johnson & Johnson Wound Management, a division of ETHICON, INC., a Johnson & Johnson company, continues the Company's 100-year commitment to skin and wound care today with inventive products for chronic and acute wound management, burn care and hemostasis. For more information about Johnson & Johnson Wound Management or other ETHICON divisions, visit or http://www.advancedwoundcare.com or http://www.ethiconinc.com.
� Silver-ORC contains 0.25 percent ionically-bound silver.
The unique combination of collagen, oxidized regenerated cellulose (ORC) and silver-ORC� delivers a balanced combination of protection and growth for a variety of wound types and conditions at any exudate level. PRISMA� Matrix removes destructive elements and components in wound fluid, kills clinically relevant bacteria in the dressing to help maintain bacterial balance and reduces bacterial growth, which may reduce the risk of infection. The dressing also promotes healthy tissue growth while delivering silver to the wound. The collagen provides a biodegradable matrix for cellular invasion and capillary growth while creating an environment that promotes the formation of granulation tissue, epithelialization and optimal wound healing.
"With PRISMA� Matrix, Johnson & Johnson Wound Management continues its pioneering role as a wound care industry leader," stated William Li, M.D., president of the Angiogenesis Foundation in Cambridge, MA. "This single product is an integrated technology that addresses multiple factors causing impaired healing. PRISMA� Matrix can be used as part of the standard approach to restoring proper balance in the wound bed to promote successful healing."
PRISMA� Matrix is intended for the management of exuding wounds. Under the supervision of a health care professional, PRISMA� Matrix may be used for the management of diabetic, venous and pressure ulcers, ulcers caused by mixed vascular etiologies, full- and partial-thickness wounds, donor sites and other bleeding surface wounds, abrasions, traumatic wounds healing by secondary intention and dehisced surgical wounds. PRISMA� Matrix may be used under compression therapy with health care professional supervision.
PRISMA� Matrix is not indicated for third-degree burns or patients with known sensitivity to silver, ORC or collagen. PRISMA� Matrix may be used when visible signs of infection are present in the wound area only when proper medical treatment addresses the underlying cause. PRISMA� Matrix is not intended to be a substitute for appropriate treatment of infection.
Johnson & Johnson Wound Management, a division of ETHICON, INC., a Johnson & Johnson company, continues the Company's 100-year commitment to skin and wound care today with inventive products for chronic and acute wound management, burn care and hemostasis. For more information about Johnson & Johnson Wound Management or other ETHICON divisions, visit or http://www.advancedwoundcare.com or http://www.ethiconinc.com.
� Silver-ORC contains 0.25 percent ionically-bound silver.
No comments:
Post a Comment